Hannah Ayrle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hannah Ayrle has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Meike Mevissen
Veterinary Pharmacology & Toxicology, Department of Clinical Research and Veterinary Public Health (DCR-VPH), University of Bern, Bern, Switzerland
3 shared publications Heiko Nathues
Department of Clinical Veterinary Medicine, Swine Clinic, Vetsuisse Faculty, University of Bern, Bremgartenstrasse 109a, Bern, 3012, Switzerland
2 shared publications- Michael Walkenhorst
Department of Livestock Sciences, Research Institute of Organic Agriculture (FiBL), Frick, Switzerland
2 shared publications - Andrea Vögtlin
Institute of Virology and Immunology (IVI), 3147 Mittelhäusern, Switzerland
1 shared publication - Andreas Schapowal
Allergy Clinic, CH-7302 Landquart, Switzerland
1 shared publication - Beatrix Falch1 shared publication
Latest Publications
- Open Access
- 27 May 2019
- Published by Springer Nature in BMC Veterinary Research
- Vol. 15 (1) , 174
Medicinal plants as therapeutic options for topical treatment in canine dermatology? A systematic review
Medicinal plants have been used traditionally since centuries for wound care and treatment of skin diseases both in human and animals. Skin diseases are one of the most common reasons for owners to take their dog to the veterinarian. The demands for treatment and prophylaxis of these diseases are broad. A wide range of bacteria including antibiotic-resistant bacteria can be involved, making the treatment challenging and bear an anthropo-zoonotic potential. The aim of this review is to systematically evaluate based on recent scientific literature, the potential of four medicinal plants to enrich the therapeutic options in pyoderma, canine atopic dermatitis, otitis externa, wounds and dermatophytosis in dogs. Based on four books and a survey among veterinarians specialized in phytotherapy, four medicinal plants were chosen as the subject of this systematic review: Calendula officinalis L. (Marigold), Hypericum perforatum L. agg. (St. John’s Wort), Matricaria chamomilla L. (syn. Matricaria recutita L., Chamomile) and Salvia officinalis L. (Sage). According to the PRISMA statement through literature research on two online databases a total of 8295 publications was screened and narrowed down to a final 138 publications for which full-text documents were analyzed for its content resulting in a total of 145 references (21 clinical, 24 in vivo and 100 in vitro references). All four plants were proven to have antibacterial and antifungal effects of a rather broad spectrum including antibiotic-resistant bacteria. This makes them an interesting new option for the treatment of pyoderma, otitis externa, infected wounds and dermatophytosis. Marigold, St. John’s Wort and Chamomile showed wound-healing properties and are thus promising candidates in line to fill the therapeutic gap in canine wound-healing agents. St. John’s Wort and Chamomile also showed anti-inflammatory and other beneficial effects on healthy skin. Due to the wide range of beneficial effects of these medicinal plants, they should be taken into account for the treatment of dermatologic diseases in dogs at least in future clinical research.
- 27 May 2019
- Published by Springer Nature in BMC Veterinary Research
- Vol. 15 (1) , 174
Open AccessMedicinal plants as therapeutic options for topical treatment in canine dermatology? A systematic review
Medicinal plants have been used traditionally since centuries for wound care and treatment of skin diseases both in human and animals. Skin diseases are one of the most common reasons for owners to take their dog to the veterinarian. The demands for treatment and prophylaxis of these diseases are broad. A wide range of bacteria including antibiotic-resistant bacteria can be involved, making the treatment challenging and bear an anthropo-zoonotic potential. The aim of this review is to systematically evaluate based on recent scientific literature, the potential of four medicinal plants to enrich the therapeutic options in pyoderma, canine atopic dermatitis, otitis externa, wounds and dermatophytosis in dogs. Based on four books and a survey among veterinarians specialized in phytotherapy, four medicinal plants were chosen as the subject of this systematic review: Calendula officinalis L. (Marigold), Hypericum perforatum L. agg. (St. John’s Wort), Matricaria chamomilla L. (syn. Matricaria recutita L., Chamomile) and Salvia officinalis L. (Sage). According to the PRISMA statement through literature research on two online databases a total of 8295 publications was screened and narrowed down to a final 138 publications for which full-text documents were analyzed for its content resulting in a total of 145 references (21 clinical, 24 in vivo and 100 in vitro references). All four plants were proven to have antibacterial and antifungal effects of a rather broad spectrum including antibiotic-resistant bacteria. This makes them an interesting new option for the treatment of pyoderma, otitis externa, infected wounds and dermatophytosis. Marigold, St. John’s Wort and Chamomile showed wound-healing properties and are thus promising candidates in line to fill the therapeutic gap in canine wound-healing agents. St. John’s Wort and Chamomile also showed anti-inflammatory and other beneficial effects on healthy skin. Due to the wide range of beneficial effects of these medicinal plants, they should be taken into account for the treatment of dermatologic diseases in dogs at least in future clinical research.
- Open Access
- 6 June 2016
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-31
Medicinal plants – prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review
Gastrointestinal and respiratory diseases in calves and piglets lead to significant economic losses in livestock husbandry. A high morbidity has been reported for diarrhea (calves ≤ 35 %; piglets ≤ 50 %) and for respiratory diseases (calves ≤ 80 %; piglets ≤ 40 %). Despite a highly diverse etiology and pathophysiology of these diseases, treatment with antimicrobials is often the first-line therapy. Multi-antimicrobial resistance in pathogens results in international accordance to strengthen the research in novel treatment options. Medicinal plants bear a potential as alternative or additional treatment. Based on the versatile effects of their plant specific multi-component-compositions, medicinal plants can potentially act as ‘multi-target drugs’. Regarding the plurality of medicinal plants, the aim of this systematic review was to identify potential medicinal plant species for prevention and treatment of gastrointestinal and respiratory diseases and for modulation of the immune system and inflammation in calves and piglets. Based on nine initial sources including standard textbooks and European ethnoveterinary studies, a total of 223 medicinal plant species related to the treatment of gastrointestinal and respiratory diseases was identified. A defined search strategy was established using the PRISMA statement to evaluate 30 medicinal plant species starting from 20’000 peer-reviewed articles published in the last 20 years (1994–2014). This strategy led to 418 references (257 in vitro, 84 in vivo and 77 clinical trials, thereof 48 clinical trials in veterinary medicine) to evaluate effects of medicinal plants and their efficacy in detail. The findings indicate that the most promising candidates for gastrointestinal diseases are Allium sativum L., Mentha x piperita L. and Salvia officinalis L.; for diseases of the respiratory tract Echinacea purpurea (L.) MOENCH, Thymus vulgaris L. and Althea officinalis L. were found most promising, and Echinacea purpurea (L.) MOENCH, Camellia sinensis (L.) KUNTZE, Glycyrrhiza glabra L. and Origanum vulgare L. were identified as best candidates for modulation of the immune system and inflammation. Several medicinal plants bear a potential for novel treatment strategies for young livestock. There is a need for further research focused on gastrointestinal and respiratory diseases in calves and piglets, and the findings of this review provide a basis on plant selection for future studies.
- 6 June 2016
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-31
Open AccessMedicinal plants – prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review
Gastrointestinal and respiratory diseases in calves and piglets lead to significant economic losses in livestock husbandry. A high morbidity has been reported for diarrhea (calves ≤ 35 %; piglets ≤ 50 %) and for respiratory diseases (calves ≤ 80 %; piglets ≤ 40 %). Despite a highly diverse etiology and pathophysiology of these diseases, treatment with antimicrobials is often the first-line therapy. Multi-antimicrobial resistance in pathogens results in international accordance to strengthen the research in novel treatment options. Medicinal plants bear a potential as alternative or additional treatment. Based on the versatile effects of their plant specific multi-component-compositions, medicinal plants can potentially act as ‘multi-target drugs’. Regarding the plurality of medicinal plants, the aim of this systematic review was to identify potential medicinal plant species for prevention and treatment of gastrointestinal and respiratory diseases and for modulation of the immune system and inflammation in calves and piglets. Based on nine initial sources including standard textbooks and European ethnoveterinary studies, a total of 223 medicinal plant species related to the treatment of gastrointestinal and respiratory diseases was identified. A defined search strategy was established using the PRISMA statement to evaluate 30 medicinal plant species starting from 20’000 peer-reviewed articles published in the last 20 years (1994–2014). This strategy led to 418 references (257 in vitro, 84 in vivo and 77 clinical trials, thereof 48 clinical trials in veterinary medicine) to evaluate effects of medicinal plants and their efficacy in detail. The findings indicate that the most promising candidates for gastrointestinal diseases are Allium sativum L., Mentha x piperita L. and Salvia officinalis L.; for diseases of the respiratory tract Echinacea purpurea (L.) MOENCH, Thymus vulgaris L. and Althea officinalis L. were found most promising, and Echinacea purpurea (L.) MOENCH, Camellia sinensis (L.) KUNTZE, Glycyrrhiza glabra L. and Origanum vulgare L. were identified as best candidates for modulation of the immune system and inflammation. Several medicinal plants bear a potential for novel treatment strategies for young livestock. There is a need for further research focused on gastrointestinal and respiratory diseases in calves and piglets, and the findings of this review provide a basis on plant selection for future studies.
- Open Access
- 1 February 2016
- Published by S. Karger AG in Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine
- Vol. 28 (1)
Autorenverzeichnis
- 1 February 2016
- Published by S. Karger AG in Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine
- Vol. 28 (1)
Open AccessAutorenverzeichnis
- Open Access
- 1 February 2016
- Published by S. Karger AG in Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine
- Vol. 28 (Suppl. 1) , 23-24
Arzneipflanzen als Therapieoption für Jungtierkrankheiten? Ein systematischer Überblick zur aktuellen Literatur
Das breite Spektrum pflanzlicher Sekundärstoffe und ihre pflanzenspezifischen Kombinationen bergen ein aktuell weitgehend ungenutztes Potenzial zur Behandlung kranker Einzeltiere, aber auch zur allgemeinen Verbesserung der Tiergesundheit. Neben optimierten Haltungs- und Hygienebedingungen sowie Massnahmen der Immunisierung könnte die Verabreichung von Arzneipflanzen (AP) eine Möglichkeit sein, den Einsatz von Antibiotika in der Nutztierhaltung zu reduzieren.
- 1 February 2016
- Published by S. Karger AG in Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine
- Vol. 28 (Suppl. 1) , 23-24
Open AccessArzneipflanzen als Therapieoption für Jungtierkrankheiten? Ein systematischer Überblick zur aktuellen Literatur
Das breite Spektrum pflanzlicher Sekundärstoffe und ihre pflanzenspezifischen Kombinationen bergen ein aktuell weitgehend ungenutztes Potenzial zur Behandlung kranker Einzeltiere, aber auch zur allgemeinen Verbesserung der Tiergesundheit. Neben optimierten Haltungs- und Hygienebedingungen sowie Massnahmen der Immunisierung könnte die Verabreichung von Arzneipflanzen (AP) eine Möglichkeit sein, den Einsatz von Antibiotika in der Nutztierhaltung zu reduzieren.